study comparing Proscar (finasteride) with Hytrin (terazosin) for BPH is causing quite a stir

September 1996

The recently published study comparing Proscar (finasteride) with Hytrin (terazosin) for BPH is causing quite a stir.

News reports are saying Proscar is "virtually worthless"... prompting lots of calls from concerned patients.

This is the same study we alerted you to last year...it's just now been published in the New England Journal of Medicine.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

patients are using herbs
study comparing Proscar (finasteride) with Hytrin (terazosin) for BPH is causing quite a stir
Antidepressants a new antidepressant, Remeron
Gastroenterology TWO new regimens for treating ulcers caused by Helicobacter pylori
Infectious Diseases new warning that quinolone antibiotics can cause inflamed or ruptured tendons
Infectious Diseases zinc lozenges for colds
Infectious Diseases SINGLE dose of acyclovir (Zovirax) to ward off fever blisters or genital herpes
first metered-dose inhaler that doesn't contain chlorofluorocarbons (CFCs)
Vaccines wide-spread vaccination for ADOLESCENTS
Cerebyx (fosphenytoin injection)
Copaxone (Co-PAX-ohn, copolymer-1 or "cop-1")
Rheumatoid Arthritis comprehensive new guidelines for treating rheumatoid arthritis (RA)
Rheumatoid Arthritis monitor rheumatoid arthritis patients for serious drug toxicities
Dermatology new acne treatment, Differin (adapalene) gel
STRONGER warnings about the new diet pill Redux (dexfenfluramine)